Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pyrin (protein encoded by the MEFV gene) is a cytosolic sensor protein mainly expressed in white blood cells involved in the innate immune response, including neutrophils, eosinophils, monocytes, and dendritic cells[2][4]. It is a member of the TRIM family and contains a unique PYD domain, essential for binding to the adaptor protein ASC and recruiting caspase-1 for IL-1β/IL-18 maturation[1][3][4]. Pyrin regulates inflammation by sensing modifications to the cytoskeletal GTPase RhoA, serving as a pattern recognition receptor for dangerous cellular disturbances, particularly those caused by pathogens[1][4]. Activation of the pyrin inflammasome drives secretion of proinflammatory cytokines and pyroptotic cell death, underpinning the pathogenesis of several autoinflammatory syndromes, most notably familial Mediterranean fever (FMF)[1][2][4]. Disease-associated mutations, especially in the C-terminal B30.2 domain, often confer gain-of-function and promote unrestrained pyrin activity, leading to excessive and inappropriate inflammation. Colchicine remains a frontline therapy, and IL-1 blockade is used in colchicine-resistant cases[2][4]. The protein interacts with multiple signaling and cytoskeletal partners (ASC, caspase-1, PKN1/2, 14-3-3 proteins), and its activity is tightly regulated by phosphorylation and oligomerization[4]. Defective regulation or pathogenic mutations result in recurrent fevers, serositis, and increased risk of amyloidosis, characteristic of FMF.
- **Colchicine:** Inhibits microtubule polymerization, thereby preventing pyrin inflammasome activation[2][4]. - **IL-1 inhibitors:** Block inflammatory downstream signaling of pyrin-induced IL-1β secretion[4]. - **Steroid hormone catabolites (in vitro):** Pregnanolone and etiocholanaolone may activate pyrin via interaction with B30.2 domain[2].
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pyrin (also known as Mediterranean fever protein) (MEFV).